Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL4462 Target Snapshot

NAD-dependent protein deacetylase sirtuin-2 · SINGLE PROTEIN · Homo sapiens

2,558Compounds
544Assays
2Approved Drugs
1,970.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt Q8IXJ6. Use UniProt Q8IXJ6 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q8IXJ6 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats NAD-dependent protein deacetylase sirtuin-2 as ChEMBL target CHEMBL4462, mapped to UniProt Q8IXJ6. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
NAD-dependent protein deacetylase sirtuin-2
SINGLE PROTEIN · Homo sapiens
As of 2026-09-14
ChEMBL target ID
CHEMBL4462
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
Q8IXJ6
NAD-dependent protein deacetylase sirtuin-2
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether NAD-dependent protein deacetylase sirtuin-2 is the right protein anchor across sources, using UniProt Q8IXJ6 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelNAD-dependent protein deacetylase sirtuin-2
UniProt AccessionQ8IXJ6
Component TypeProtein
Sequence Length389 aa

NAD-dependent protein deacetylase sirtuin-2

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as NAD-dependent protein deacetylase sirtuin-2, mapped to UniProt Q8IXJ6. Sequence length is 389 aa.

Mapped IDQ8IXJ6
Review nameNAD-dependent protein deacetylase sirtuin-2
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

2
Approved
2
Phase III
1
Phase II
Assay Mix

Activity Type Distribution

IC501,910.0
KI44.0
EC507.0
KD9.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL3769432 9.0 IC50 1.0 Preclinical
CHEMBL2338810 8.96 IC50 1.1 Preclinical
CHEMBL2332037 8.89 IC50 1.3 Preclinical
CHEMBL2332041 8.74 IC50 1.8 Preclinical
CHEMBL2332039 8.57 IC50 2.7 Preclinical
CHEMBL5614132 8.57 IC50 2.7 Preclinical
CHEMBL3779989 8.49 IC50 3.2 Preclinical
CHEMBL2332042 8.36 IC50 4.4 Preclinical
CHEMBL2332040 8.32 IC50 4.8 Preclinical
CHEMBL2332044 8.27 IC50 5.4 Preclinical
Distribution

pChEMBL Value Distribution

291
5.0
184
5.5
107
6.0
102
6.5
71
7.0
38
7.5
10
8.0
5
8.5
1
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

544
Total Assays
1,055
Tested Compounds
3
Assay Types
Binding — 528 assays, 1,055 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 317 646 5.4
assay format 116 367 5.7
cell-based format 94 42 5.6
tissue-based format 1 0
ADME — 15 assays, 11 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 12 11 5.0
assay format 2 0
cell-based format 1 0
Functional — 1 assays, 0 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 1 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine